Global Marine Drug Market Size, Status and Forecast 2020-2026
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Marine Drug Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Marine Drug Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Drugs
- 1.4.3 Health Supplement
- 1.5 Market by Application
- 1.5.1 Global Marine Drug Market Share by Application: 2020 VS 2026
- 1.5.2 Hospital & Clinic
- 1.5.3 Pharmacy
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends by Regions
- 2.1 Marine Drug Market Perspective (2015-2026)
- 2.2 Marine Drug Growth Trends by Regions
- 2.2.1 Marine Drug Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Marine Drug Historic Market Share by Regions (2015-2020)
- 2.2.3 Marine Drug Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Marine Drug Market Growth Strategy
- 2.3.6 Primary Interviews with Key Marine Drug Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Marine Drug Players by Market Size
- 3.1.1 Global Top Marine Drug Players by Revenue (2015-2020)
- 3.1.2 Global Marine Drug Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Marine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Marine Drug Market Concentration Ratio
- 3.2.1 Global Marine Drug Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Marine Drug Revenue in 2019
- 3.3 Marine Drug Key Players Head office and Area Served
- 3.4 Key Players Marine Drug Product Solution and Service
- 3.5 Date of Enter into Marine Drug Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Marine Drug Historic Market Size by Type (2015-2020)
- 4.2 Global Marine Drug Forecasted Market Size by Type (2021-2026)
5 Marine Drug Breakdown Data by Application (2015-2026)
- 5.1 Global Marine Drug Market Size by Application (2015-2020)
- 5.2 Global Marine Drug Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Marine Drug Market Size (2015-2020)
- 6.2 Marine Drug Key Players in North America (2019-2020)
- 6.3 North America Marine Drug Market Size by Type (2015-2020)
- 6.4 North America Marine Drug Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Marine Drug Market Size (2015-2020)
- 7.2 Marine Drug Key Players in Europe (2019-2020)
- 7.3 Europe Marine Drug Market Size by Type (2015-2020)
- 7.4 Europe Marine Drug Market Size by Application (2015-2020)
8 China
- 8.1 China Marine Drug Market Size (2015-2020)
- 8.2 Marine Drug Key Players in China (2019-2020)
- 8.3 China Marine Drug Market Size by Type (2015-2020)
- 8.4 China Marine Drug Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Marine Drug Market Size (2015-2020)
- 9.2 Marine Drug Key Players in Japan (2019-2020)
- 9.3 Japan Marine Drug Market Size by Type (2015-2020)
- 9.4 Japan Marine Drug Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Marine Drug Market Size (2015-2020)
- 10.2 Marine Drug Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Marine Drug Market Size by Type (2015-2020)
- 10.4 Southeast Asia Marine Drug Market Size by Application (2015-2020)
11 India
- 11.1 India Marine Drug Market Size (2015-2020)
- 11.2 Marine Drug Key Players in India (2019-2020)
- 11.3 India Marine Drug Market Size by Type (2015-2020)
- 11.4 India Marine Drug Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Marine Drug Market Size (2015-2020)
- 12.2 Marine Drug Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Marine Drug Market Size by Type (2015-2020)
- 12.4 Central & South America Marine Drug Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Seattle Genetics
- 13.1.1 Seattle Genetics Company Details
- 13.1.2 Seattle Genetics Business Overview and Its Total Revenue
- 13.1.3 Seattle Genetics Marine Drug Introduction
- 13.1.4 Seattle Genetics Revenue in Marine Drug Business (2015-2020))
- 13.1.5 Seattle Genetics Recent Development
- 13.2 DSM
- 13.2.1 DSM Company Details
- 13.2.2 DSM Business Overview and Its Total Revenue
- 13.2.3 DSM Marine Drug Introduction
- 13.2.4 DSM Revenue in Marine Drug Business (2015-2020)
- 13.2.5 DSM Recent Development
- 13.3 Eisai Co
- 13.3.1 Eisai Co Company Details
- 13.3.2 Eisai Co Business Overview and Its Total Revenue
- 13.3.3 Eisai Co Marine Drug Introduction
- 13.3.4 Eisai Co Revenue in Marine Drug Business (2015-2020)
- 13.3.5 Eisai Co Recent Development
- 13.4 Takeda
- 13.4.1 Takeda Company Details
- 13.4.2 Takeda Business Overview and Its Total Revenue
- 13.4.3 Takeda Marine Drug Introduction
- 13.4.4 Takeda Revenue in Marine Drug Business (2015-2020)
- 13.4.5 Takeda Recent Development
- 13.5 BASF
- 13.5.1 BASF Company Details
- 13.5.2 BASF Business Overview and Its Total Revenue
- 13.5.3 BASF Marine Drug Introduction
- 13.5.4 BASF Revenue in Marine Drug Business (2015-2020)
- 13.5.5 BASF Recent Development
- 13.6 Amway
- 13.6.1 Amway Company Details
- 13.6.2 Amway Business Overview and Its Total Revenue
- 13.6.3 Amway Marine Drug Introduction
- 13.6.4 Amway Revenue in Marine Drug Business (2015-2020)
- 13.6.5 Amway Recent Development
- 13.7 Pfizer
- 13.7.1 Pfizer Company Details
- 13.7.2 Pfizer Business Overview and Its Total Revenue
- 13.7.3 Pfizer Marine Drug Introduction
- 13.7.4 Pfizer Revenue in Marine Drug Business (2015-2020)
- 13.7.5 Pfizer Recent Development
- 13.8 Pelagia (EPAX)
- 13.8.1 Pelagia (EPAX) Company Details
- 13.8.2 Pelagia (EPAX) Business Overview and Its Total Revenue
- 13.8.3 Pelagia (EPAX) Marine Drug Introduction
- 13.8.4 Pelagia (EPAX) Revenue in Marine Drug Business (2015-2020)
- 13.8.5 Pelagia (EPAX) Recent Development
- 13.9 Pharma Mar SA
- 13.9.1 Pharma Mar SA Company Details
- 13.9.2 Pharma Mar SA Business Overview and Its Total Revenue
- 13.9.3 Pharma Mar SA Marine Drug Introduction
- 13.9.4 Pharma Mar SA Revenue in Marine Drug Business (2015-2020)
- 13.9.5 Pharma Mar SA Recent Development
- 13.10 Croda
- 13.10.1 Croda Company Details
- 13.10.2 Croda Business Overview and Its Total Revenue
- 13.10.3 Croda Marine Drug Introduction
- 13.10.4 Croda Revenue in Marine Drug Business (2015-2020)
- 13.10.5 Croda Recent Development
- 13.11 GNC
- 10.11.1 GNC Company Details
- 10.11.2 GNC Business Overview and Its Total Revenue
- 10.11.3 GNC Marine Drug Introduction
- 10.11.4 GNC Revenue in Marine Drug Business (2015-2020)
- 10.11.5 GNC Recent Development
- 13.12 GSK
- 10.12.1 GSK Company Details
- 10.12.2 GSK Business Overview and Its Total Revenue
- 10.12.3 GSK Marine Drug Introduction
- 10.12.4 GSK Revenue in Marine Drug Business (2015-2020)
- 10.12.5 GSK Recent Development
- 13.13 TerSera Therapeutics
- 10.13.1 TerSera Therapeutics Company Details
- 10.13.2 TerSera Therapeutics Business Overview and Its Total Revenue
- 10.13.3 TerSera Therapeutics Marine Drug Introduction
- 10.13.4 TerSera Therapeutics Revenue in Marine Drug Business (2015-2020)
- 10.13.5 TerSera Therapeutics Recent Development
- 13.14 Nordic Naturals
- 10.14.1 Nordic Naturals Company Details
- 10.14.2 Nordic Naturals Business Overview and Its Total Revenue
- 10.14.3 Nordic Naturals Marine Drug Introduction
- 10.14.4 Nordic Naturals Revenue in Marine Drug Business (2015-2020)
- 10.14.5 Nordic Naturals Recent Development
- 13.15 Carlson Labs
- 10.15.1 Carlson Labs Company Details
- 10.15.2 Carlson Labs Business Overview and Its Total Revenue
- 10.15.3 Carlson Labs Marine Drug Introduction
- 10.15.4 Carlson Labs Revenue in Marine Drug Business (2015-2020)
- 10.15.5 Carlson Labs Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
This report focuses on the global Marine Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Marine Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs
Market segment by Type, the product can be split into
Drugs
Health Supplement
Market segment by Application, split into
Hospital & Clinic
Pharmacy
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Marine Drug status, future forecast, growth opportunity, key market and key players.
To present the Marine Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Marine Drug are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.